Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

From 2010 to 2023, GLP-1RAs and SGLT2 inhibitors saw rising prescriptions in type 1 diabetes, particularly for patients with obesity and cardiorenal risks.

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

MAPS Unveils Improved Fiscal Sponsorship Program, Empowering Innovators in the Psychedelic Movement | Psychedelic Invest

To date, MAPS has supported nearly 70 organizations worldwide to advance charitable projects in the psychedelic movement Currently, MAPS serves as a fiscal sponsor for

January 17, 2024

Thrivelab Launches Affordable Virtual Menopause Care for Women

What You Should Know: – Thrivelab, a provider of hormone health services, is addressing the women’s health crisis by launching accessible and affordable virtual menopause

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.